LAPTM4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.909200E-01
Normal-vs-Stage2
9.312000E-01
Normal-vs-Stage3
9.346400E-01
Normal-vs-Stage4
4.178800E-01
Stage1-vs-Stage2
4.957800E-01
Stage1-vs-Stage3
6.491000E-01
Stage1-vs-Stage4
7.696000E-02
Stage2-vs-Stage3
9.219200E-01
Stage2-vs-Stage4
1.263750E-01
Stage3-vs-Stage4
3.833000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.866200E-01
Normal-vs-AfricanAmerican
6.273400E-01
Normal-vs-Asian
7.406200E-01
Caucasian-vs-AfricanAmerican
3.253800E-01
Caucasian-vs-Asian
4.239800E-01
AfricanAmerican-vs-Asian
1.671560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.215000E-01
Normal-vs-Female
8.214800E-01
Male-vs-Female
2.158400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.772400E-01
Normal-vs-Age(41-60Yrs)
5.127000E-01
Normal-vs-Age(61-80Yrs)
8.383200E-01
Normal-vs-Age(81-100Yrs)
9.748200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.237600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.225000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.348100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.256500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.428230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.133200E-01
Normal-vs-Daily Drinker
9.320600E-01
Normal-vs-Weekly Drinker
7.784000E-01
Normal-vs-Occasional Drinker
8.025800E-01
Normal-vs-Social Drinker
9.679000E-01
Non Drinker-vs-Daily Drinker
7.870400E-01
Non Drinker-vs-Weekly Drinker
8.625200E-01
Non Drinker-vs-Occasional Drinker
1.082960E-01
Non Drinker-vs-Social Drinker
7.083000E-01
Daily Drinker-vs-Weekly Drinker
7.235800E-01
Daily Drinker-vs-Occasional Drinker
2.828800E-01
Daily Drinker-vs-Social Drinker
9.243200E-01
Weekly Drinker-vs-Occasional Drinker
1.223360E-01
Weekly Drinker-vs-Social Drinker
6.511000E-01
Occasional Drinker-vs-Social Drinker
3.214000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.139000E-01
Normal-vs-Grade 2
7.083500E-03
Normal-vs-Grade 3
2.008300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.225200E-04
Grade 1-vs-Grade 3
1.530140E-02
Grade 1-vs-Grade 4
2.139000E-01
Grade 2-vs-Grade 3
4.433400E-01
Grade 2-vs-Grade 4
7.083500E-03
Grade 3-vs-Grade 4
2.008300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.813400E-01
Normal-vs-NonDiabetic
9.383800E-01
Diabetic-vs-NonDiabetic
8.806200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.718600E-01
Normal-vs-NoPancreatitis
9.476000E-01
Pancreatitis-vs-NoPancreatitis
4.572800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.636800E-01
Normal-vs-N1
8.561800E-01
N0-vs-N1
2.001000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.578200E-01
Normal-vs-TP53-NonMutant
5.163600E-01
TP53-Mutant-vs-TP53-NonMutant
1.254410E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
